Products Site 10/30 Takara Bio receives NEDO Grant to develop mass production of cardiomyocytes derived from human iPS cells 05/08 Takara Bio Group’s Mid-term Management Plan 05/01 Takara Bio submitted an Investigational New Drug application for a Phase II clinical trial of HF10 anti-cancer therapy to the Food and Drug Administration 03/13 Clinical research protocol of gene therapy targeting B cell non-Hodgkin Lymphoma was approved by Japanese Ministry 03/03 Takara Bio obtains a governmental grant for commercialization of its TCR gene therapy projects return to top Message from the president Corporate Data Corporate Executives Directions to Takara Bio Corporate Governance Consolidated Subsidiaries Bioindustry Gene Therapy AgriBio Copyright © TAKARA BIO INC. All rights reserved.

Products Site HOME>About Us>Consolidated Subsidiaries Consolidated Subsidiaries Consolidated Subsidiaries : Takara Biotechnology (Dalian) Co., Ltd. Takara Korea Biomedical Inc. Takara Bio USA Holdings Inc. Clontech Laboratories, Inc. Takara Bio Europe S.A.S. Takara Bio Europe AB Takara Biomedical Technology (Beijing) Co., Ltd. DSS Takara Bio India Pvt. Ltd. Mizuho Norin Co., Ltd. Takara Bio Farming Center Inc. KINOKO CENTER KIN INC. About Us Message from the president Corporate Data Corporate Executives Directions to Takara Bio Corporate Governance Consolidated Subsidiaries return to top Message from the president Corporate Data Corporate Executives Directions to Takara Bio Corporate Governance Consolidated Subsidiaries Bioindustry Gene Therapy AgriBio Copyright © TAKARA BIO INC. All rights reserved.